looks to me like the market has had a bit of a rethink on Patrys? at first there was a big fuss about Onyx funding the clinical trials, but it turned out not quite to be the case, then there were the exaggerated results of PAB drug on MM trials, turns out that there are indications of possible efficacy but nothing conclusive yet.
the jury's out on this one it seems to me and likely to stay that way until a lot more is known about sc1 etc.
PAB Price at posting:
6.0¢ Sentiment: None Disclosure: Not Held
